Advertisement

Topics

Endo unit cleared of liability in first testosterone replacement trial

16:21 EST 17 Nov 2017 | Topix

NEW YORK: A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim. The verdict was a victory for the drugmaker in its first trial over allegations it defectively designed Testim, a skin gel, and negligently misrepresented its risks.

Original Article: Endo unit cleared of liability in first testosterone replacement trial

NEXT ARTICLE

More From BioPortfolio on "Endo unit cleared of liability in first testosterone replacement trial"

Quick Search
Advertisement